Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan

NCT07869264 is registered in ClinicalTrials.gov with Eisai Taiwan Inc. as lead sponsor.

NCT NCT07869264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan
Lead sponsor
Eisai Taiwan Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 29, 2026
Completion date
September 30, 2030
Enrollment
100 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease